Cor Vasa 2023, 65(1):116-119 | DOI: 10.33678/cor.2022.064
Post‑infectious acute myocardial infarction following COVID‑19 infection in a young patient
- a Cardiology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
- b Interventional Cardiology Unit, Department of Cardiology, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy
- c Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Policlinico Universitario Umberto I, Sapienza University of Rome, Rome, Italy
It is now widely known that COVID-19 can also cause various extrapulmonary manifestations. Possible mechanisms of cardiovascular damage include direct myocardial damage due to hypercoagulability caused by systemic inflammation, which may also lead to destabilisation of coronary plaques. We present a case of a 30-year-old young man following asymptomatic COVID-19 infection, who was admit- ted to the emergency room of the Grande Ospedale Metropolitano di Reggio Calabria, Italy, with typical chest pain. The patient had no cardiovascular disease, cardiovascular risk factors including no family history of cardiovascular disease. Urgent coronary angiography showed critical stenosis of the middle-proximal portion of the left anterior descending artery (80%) with ulcerated plaque appearance. Regardless of cardiovascular risk factors, our case report emphasises the need to determine COVID-19 status in all patients with acute myocardial infarction during this pandemic.
Keywords: Acute myocardial infarction, Cardiovascular disease, COVID-19, Young patients,
Received: April 10, 2022; Revised: April 10, 2022; Accepted: June 2, 2022; Published: March 1, 2023 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Stefanini GG, Montorfano M, Trabattoni D, et al. ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. Circulation 2020;141:2113-2116.
Go to original source...
Go to PubMed...
- Huertas A, Montani D, Savale L, et al. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J 2020;56:2001634.
Go to original source...
Go to PubMed...
- Musher DM, Abers MS, Corrales-Medina VF. Acute Infection and Myocardial Infarction. N Engl J Med 2019;380:171-176.
Go to original source...
Go to PubMed...
- Sisakian H, Martirosyan S, Shekoyan S, et al. Asymptomatic COVID-19 and ST-elevation myocardial infarction in young adults: lessons learned from two similar cases. ESC Heart Fail 2022;9:775-781.
Go to original source...
Go to PubMed...
- Caminiti R, Colarusso L, Vizzari G, Crea P. Tolerance of sustained ventricular fibrillation during left ventricular assist device support with IMPELLA CP®. Cardiovasc Revasc Med 2022;40S:305-307.
Go to original source...
Go to PubMed...
- Bangalore S, Sharma A, Slotwiner A, et al. ST-Segment Elevation in Patients with Covid-19 - A Case Series. N Engl J Med 2020;382:2478-2480.
Go to original source...
Go to PubMed...
- Afshar ZM, Babazadeh A, Javanian M, et al. A review of cardiac involvement in COVID-19 infection. Cor Vasa 2020;62:610-615.
Go to original source...
- Varvařovský I, Mates M, Bernat I, et al. Working in the cathlab during COVID-19 pandemic. Cor Vasa 2020;62(Suppl.1):34-36.
Go to original source...
- Casale M, Imbalzano E, Morabito C, et al. Early antithrombotic therapy and COVID-19: a better clinical course? New evidences from real-life cases. Cor Vasa 2020;62(Suppl.1):37-40.
Go to original source...
- Ferri C, Giuggioli D, Raimondo V, et al. Covid-19 and rheumatic autoimmune systemic diseases: Role of pre-existing lung involvement and ongoing treatments. Curr Pharm Des. 2021;27:4245-4252.
Go to original source...
Go to PubMed...
- Skoda R, Fülöp G, Csulak E, et al. The secondary effect of the first wave of COVID-19 and its consequences on myocardial infarction care in a high volume Hungarian cardiovascular centre. Cor Vasa 2021;63:345-349.
Go to original source...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.